Aurobindo Pharma to acquire 26% stake in Swarnaakshu Solar Power for captive renewable energy project
Type: Acquisition · Technology: Solar · Country: India · Announced: 2026-04-06
Aurobindo Pharma plans to acquire a 26% stake in Swarnaakshu Solar Power to secure renewable energy for its operations. This investment aims to develop a solar project for internal electricity use, enhancing cost efficiency and sustainability for Aurobindo Pharma. The deal aligns with India’s regulations for captive power generation, emphasizing the industry's shift toward renewable solutions. This acquisition will support Aurobindo Pharma's energy needs and contribute to its sustainability goals.
Analysis
Aurobindo Pharma announced its intention to acquire a 26% stake in Swarnaakshu Solar Power in India. This acquisition is for a captive renewable energy project. The deal was announced on April 6, 2026. Swarnaakshu Solar Power is the seller in this transaction.
Key points
- Aurobindo Pharma to acquire 26% stake in Swarnaakshu Solar Power
- Deal type: acquisition
- Technology/Sector: solar
- Location: India
- Announced: 2026-04-06
Counterparties
- Swarnaakshu Solar Power (Seller)
- Aurobindo Pharma (Buyer)